Vitrolife AB
Medical Devices · Healthcare
1 appearance
Latest appearance 2026-02-03
Analyst
SEB
Equibles does not estimate personal net worth.
Jacob Lemke is recorded as Analyst at SEB. Jacob Lemke has spoken on 1 earnings call across 1 company, most recently for Vitrolife AB on February 3, 2026. The companies whose calls Jacob Lemke spoke on are classified in the Healthcare sector.
“I just want to clarify that is this mainly related to the sort of different business mix you have in the regions or the anything else behind that in the regional mix and then also if you could sort of give an indication of sort of a 58 59 percent cross margin is a new normal we should expect going forward.”
SEB
Analyst
Transcript header (unverified)
Vitrolife AB
Medical Devices · Healthcare
Vitrolife, Audiocast, Q4'25
Vitrolife AB